Evolving personal work patterns are demonstrating people’s amazing adaptability in the face of the pandemic: people are becoming much more comfortable and efficient at using virtual meetings, European Biotech leaders reveal to Egon Zehnder in a recent digital gathering.

On June 30, Egon Zehnder virtually gathered 15 top HR leaders from across biopharma, including European-based and U.S.-based companies, ranging from big pharma to start-up biotech. It was a lively discussion, with participants curious to learn from one another and generous in sharing their own insights, hopes, and concerns.

Highlights from the fourth round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder.

Highlights from the second round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder.

Senior Biotech R&D execs brainstorm on saving clinical trials, modifying procedures, and getting people back to work.

Egon Zehnder's lessons from how the biopharma industry has responded to Covid-19 with focus, collaboration and resilience.

Healthcare CEOs in Asia have embraced that duality and in a teleconference organized by Egon Zehnder, they gathered to discuss the fallout from COVID-19.

The pharma and healthcare sector faces a serious threat of operational challenges due to COVID-19. Operations leaders gather to discuss how to move forward.

On April 8 and 9 Egon Zehnder virtually convened a number of biotech board directors to discuss some of the challenges being faced by their companies, often on the front line of responding to COVID-19.

On March 28, our global health care practice convened a virtual meeting with 15 CEOs around the world to discuss how to ensure financial strength, secure the supply chain, and the future of clinical trials.